The global demand for Cell Therapy Manufacturing Market is presumed to reach the market size of nearly USD 15043.87 Million by 2032 from USD 4210.05 Million in 2023 with a CAGR of 15.2% under the study period 2024 - 2032.
Cell therapy manufacturing starts with the patient's cells being collected in a clinic and ends with the patient receiving the finished drug product at their bedside. Between the initial raw material collection and the subsequent product administration, numerous hand-off points and activities occur. Due to the many moving parts in a supply chain and the production and distribution phases combined, cell therapy manufacturing is different from standard pharmaceutical production. Cell therapies given to patients are only intended to help a small number of patients.
The cell therapy manufacturing market will be driven by the exponential growth of the clinical pipeline and the rising number of regulatory approvals for advanced therapies. Increasing practices of manufacturing capability outsourcing and the rising prevalence of diseases and other cell-related disorders are some factors propelling the market growth of cell therapy manufacturing. Furthermore, a rapid surge in R&D activities and increasing expenditure to initiate regenerative cell medicine manufacturing is another factor fostering the market growth of cell therapy manufacturing. The increasing demand for cell therapies in treating chronic diseases such as cancer, hereditary immunological disorders, viral infections, and hemoglobinopathies is a significant factor influencing the market growth for cell therapy manufacturing.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cell therapy manufacturing. The growth and trends of cell therapy manufacturing industry provide a holistic approach to this study.
This section of the cell therapy manufacturing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Source
By Indication
By Manufacturing Purpose
By Route Of Administration
By Cell Type
By End User
This section covers the regional outlook, which accentuates current and future demand for the Cell Therapy Manufacturing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cell Therapy Manufacturing market include Merck KGaA, Avantor Inc., Cell Therapies Pty Ltd, Thermo Fisher Scientific, Charles River Laboratories, Catalent Inc, Bio-Techne, Cytiva, Lonza, The Discovery Labs, Biocentriq, Fujifilm Diosynth Biotechnologies, Novartis AG, Bristol-Myers Squibb Company, Gilead Sciences Inc., WuXi AppTec., Oxgene, Pharmaron. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . CELL THERAPY MANUFACTURING – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Source
3.7.2 Market Attractiveness Analysis By Indication
3.7.3 Market Attractiveness Analysis By Manufacturing Purpose
3.7.4 Market Attractiveness Analysis By Route Of Administration
3.7.5 Market Attractiveness Analysis By Cell Type
3.7.6 Market Attractiveness Analysis By End User
3.7.7 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL CELL THERAPY MANUFACTURING MARKET ANALYSIS BY SOURCE
5.1 Overview by Source
5.2 Historical and Forecast Data
5.3 Analysis by Source
5.4 Autologous Historic and Forecast Sales by Regions
5.5 Allogenic Historic and Forecast Sales by Regions
6 . GLOBAL CELL THERAPY MANUFACTURING MARKET ANALYSIS BY INDICATION
6.1 Overview by Indication
6.2 Historical and Forecast Data
6.3 Analysis by Indication
6.4 HIV Historic and Forecast Sales by Regions
